Multiple Sclerosis News

WEST PALM BEACH, Fla. — Treatment with clemastine fumarate was linked to accelerated disease and disability progression due to pyroptosis in a small cohort of individuals with multiple sclerosis, according to a presenter at ACTRIMS 2024.

The FDA has approved breakthrough device designation for a novel neuroimmune modulation platform for those with relapsing-remitting multiple sclerosis, according to the manufacturer.

WEST PALM BEACH, Fla. — Treatment with evobrutinib was nonsuperior to teriflunomide in confirmed disability progression at 12 and 24 weeks for those with relapsing forms of multiple sclerosis, according to a presenter at ACTRIMS 2024.

WEST PALM BEACH, Fla. — The “wearing-off” effect with monoclonal antibodies prescribed for multiple sclerosis led to treatment dissatisfaction and was associated with depression, according to a poster from ACTRIMS 2024.

WEST PALM BEACH, Fla. — In-home video taken by adults with multiple sclerosis is a feasible and valid method to determine the mechanism and motion of their gait, according to a poster from ACTRIMS 2024.

WEST PALM BEACH, Fla. — Variability and length of pauses in speech may indicate cognitive impairment for German-speaking individuals with multiple sclerosis, according to a poster from ACTRIMS 2024.

The FDA has declined to approve a new drug application for GA Depot 40 mg, a long-acting glatiramer acetate under investigation as a once-monthly injection for those with relapsing forms of multiple sclerosis, according to a press release

WEST PALM BEACH, Fla. — Hispanic and Latino individuals with neuromyelitis optica spectrum disorder experienced improved outcomes with Uplizna compared with placebo, according to a poster from ACTRIMS 2024.

WEST PALM BEACH, Fla. — Among residents and attending physicians at an Ivy League medical center, disparities exist in knowledge and understanding of care for those with multiple sclerosis, according to a poster from ACTRIMS 2024.

WEST PALM BEACH, Fla. — No correlation was found between depression and self-report of disability in a small group of patients with multiple sclerosis, according to a poster from ACTRIMS 2024.